{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Outpatient&page=9", "query": { "condition": "Outpatient", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 889, "total_pages": 89, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Outpatient&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Outpatient&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T07:57:27.531Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01096550", "title": "Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Drug Dependence" ], "interventions": [ { "name": "Outpatient", "type": "BEHAVIORAL" }, { "name": "Intensive Outpatient", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Friends Research Institute, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 319, "start_date": "2010-03", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2020-04-08", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01096550" }, { "nct_id": "NCT00143091", "title": "Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "CP-316,311", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2005-04", "completion_date": "2006-04", "has_results": false, "last_update_posted_date": "2008-03-24", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 2, "location_summary": "Bellevue, Washington • Seattle, Washington", "locations": [ { "city": "Bellevue", "state": "Washington" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00143091" }, { "nct_id": "NCT04518410", "title": "ACTIV-2: A Study for Outpatients With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Coronavirus", "Covid19" ], "interventions": [ { "name": "bamlanivimab 7000mg", "type": "BIOLOGICAL" }, { "name": "BRII-196+BRII-198", "type": "BIOLOGICAL" }, { "name": "AZD7442 (IV)", "type": "BIOLOGICAL" }, { "name": "AZD7442 (IM)", "type": "BIOLOGICAL" }, { "name": "SNG001", "type": "DRUG" }, { "name": "Camostat", "type": "DRUG" }, { "name": "BMS-986414 + BMS-986413", "type": "BIOLOGICAL" }, { "name": "SAB-185 (3,840 Units/kg)", "type": "BIOLOGICAL" }, { "name": "SAB-185 (10,240 Units/kg)", "type": "BIOLOGICAL" }, { "name": "CASIRIVIMAB + IMDEVIMAB", "type": "DRUG" }, { "name": "Placebo for Bamlanivimab 7000mg", "type": "DRUG" }, { "name": "Placebo for Bamlanivimab 700mg", "type": "DRUG" }, { "name": "Placebo for BRII-196+BRII-198", "type": "DRUG" }, { "name": "Placebo for SNG001", "type": "DRUG" }, { "name": "Placebo for Camostat", "type": "DRUG" }, { "name": "Placebo for SAB-185 (low dose)", "type": "DRUG" }, { "name": "Placebo for BMS-986414 + BMS-986413", "type": "DRUG" }, { "name": "Placebo for AZD7442 (IV)", "type": "DRUG" }, { "name": "Placebo for AZD7442 (IM)", "type": "DRUG" }, { "name": "Placebo for SAB-185 (high dose)", "type": "DRUG" }, { "name": "bamlanivimab 700mg", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4044, "start_date": "2020-08-19", "completion_date": "2023-06-20", "has_results": true, "last_update_posted_date": "2024-08-02", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 207, "location_summary": "Anniston, Alabama • Athens, Alabama • Birmingham, Alabama + 143 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04518410" }, { "nct_id": "NCT06106360", "title": "A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Solid Tumor", "Hematological Malignancy" ], "interventions": [ { "name": "Locus Health iPhone App", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Inova Health Care Services", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2023-10-26", "completion_date": "2026-12-26", "has_results": false, "last_update_posted_date": "2026-09-25", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 1, "location_summary": "Fairfax, Virginia", "locations": [ { "city": "Fairfax", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06106360" }, { "nct_id": "NCT03725397", "title": "Inpatient Versus Outpatient Foley Cervical Ripening Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Induced; Birth" ], "interventions": [ { "name": "Outpatient", "type": "BEHAVIORAL" }, { "name": "Inpatient", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 54, "start_date": "2019-01-08", "completion_date": "2022-06-27", "has_results": false, "last_update_posted_date": "2023-02-22", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 2, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03725397" }, { "nct_id": "NCT06378359", "title": "Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Staphylococcus Aureus Colonization", "Surgical Site Infections", "Healthcare Associated Infections" ], "interventions": [ { "name": "Screening and decolonization for SA carriers with the 3 drug bundle", "type": "OTHER" }, { "name": "No screening for SA", "type": "OTHER" }, { "name": "no screening", "type": "OTHER" }, { "name": "Nasal povidone-iodine on surgery day plus 2 CHG pre-op showers without screening.", "type": "OTHER" }, { "name": "Nasal alcohol gel on surgery day plus 2 CHG pre-op showers without screening", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2024-01-29", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-01-14", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT06378359" }, { "nct_id": "NCT00435227", "title": "A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Participants Less Than 12 Months of Age With RSV Illness" ], "interventions": [ { "name": "Motavizumab", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "MedImmune LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "0 Months to 12 Months" }, "enrollment_count": 12, "start_date": "2007-03-20", "completion_date": "2008-05-31", "has_results": true, "last_update_posted_date": "2021-08-17", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 31, "location_summary": "Tucson, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 24 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00435227" }, { "nct_id": "NCT06672042", "title": "Parental Adherence of a Mobile Application", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pediatrics", "Medically Complex", "Children With Medical Complexity (CMC)", "Nursing" ], "interventions": [ { "name": "CHAMP App", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Children's Mercy Hospital Kansas City", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": null, "sex": "ALL", "summary": "0 Years and older" }, "enrollment_count": 0, "start_date": "2025-08", "completion_date": "2028-08", "has_results": false, "last_update_posted_date": "2025-04-10", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 1, "location_summary": "Kansas City, Missouri", "locations": [ { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT06672042" }, { "nct_id": "NCT07024498", "title": "Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "care coordination implementation strategies", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "14 Years", "maximum_age": null, "sex": "ALL", "summary": "14 Years and older" }, "enrollment_count": 3492, "start_date": "2025-11-01", "completion_date": "2029-08-01", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 4, "location_summary": "El Centro, California • Irvine, California • Placerville, California + 1 more", "locations": [ { "city": "El Centro", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "Placerville", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07024498" }, { "nct_id": "NCT03113409", "title": "Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Opioid-use Disorder" ], "interventions": [ { "name": "Buprenorphine", "type": "DRUG" }, { "name": "Naltrexone", "type": "DRUG" }, { "name": "Vivitrol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New York State Psychiatric Institute", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 10, "start_date": "2017-06-01", "completion_date": "2020-12-01", "has_results": true, "last_update_posted_date": "2022-03-02", "last_synced_at": "2026-10-23T07:57:27.531Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03113409" } ] }